Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Johnson & Johnson (NYSE:JNJ)

113.06
Delayed Data
As of May 27
 +0.16 / +0.14%
Today’s Change
81.79
Today|||52-Week Range
115.00
+10.07%
Year-to-Date
Billionaires Are Gobbling Up Johnson & Johnson's Stock -- Should You?
May 27 / MotleyFool.com - Paid Partner Content
'Party Drug' Could Be Johnson & Johnson's Entry Into Antidepressant Market
May 22 / GuruFocus News - Paid Partner Content
3 Small Biotechs That Look Very Healthy
May 27 / TheStreet.com - Paid Partner Content
The 3 Best Retirement Funds for Your 401(k)
May 21 / MotleyFool.com - Paid Partner Content
3 Stand-Out Health Care Stocks for Dividends and Growth
May 27 / TheStreet.com - Paid Partner Content
An unhappy anniversary for the bull market
May 20 / CNNMoney.com
Zacks Investment Ideas feature highlights: Canadian Pacific Railway, Facebook and Joh...
May 27 / Zacks.com - Paid Partner Content
In Your 60s? 3 Stocks You Should Consider Buying
May 20 / MotleyFool.com - Paid Partner Content
Cooper Companies Arm Acquires Recombine Assets for $85M
May 27 / Zacks.com - Paid Partner Content
Roche Gets Accelerated Approval for Immunotherapy Drug
May 19 / Zacks.com - Paid Partner Content
Minerva Surges on Positive Results on Depression Candidate
May 27 / Zacks.com - Paid Partner Content
Bear of the Day: AbbVie (ABBV)
May 18 / Zacks.com - Paid Partner Content
How to Buy Momentum, Trade Options and Short Stocks
May 26 / Zacks.com - Paid Partner Content
Catalyst (CPRX) Resorts to Layoffs for Firdapse Development
May 18 / Zacks.com - Paid Partner Content
Seattle Genetics Starts Trial on Acute Myeloid Leukemia Drug
May 26 / Zacks.com - Paid Partner Content
3 Perfect Stocks for Retirees in Their 60s to Consider Buying
May 17 / MotleyFool.com - Paid Partner Content
Dr. Reddy's (RDY) Acquires Ducere Pharma's OTC Brands
May 26 / Zacks.com - Paid Partner Content
The 3 Best Dividend Mutual Funds
May 17 / MotleyFool.com - Paid Partner Content
Hedge Funds Are Buying These Stocks, Should You?
May 26 / Zacks.com - Paid Partner Content
Aegerion (AEGR) Misses Q1 Earnings Estimates, Cuts View
May 17 / Zacks.com - Paid Partner Content
Jim Cramer -- Despite Rally, HP Earnings Not Impressive
May 26 / TheStreet.com - Paid Partner Content
Novartis (NVS) Releases Positive Data on Ultibro Breezhaler
May 16 / Zacks.com - Paid Partner Content
Novo Nordisk IDegLira Recommended by FDA Advisory Committee
May 25 / Zacks.com - Paid Partner Content
Drug Stocks Reporting Earnings on May 17: AXON & FWP
May 16 / Zacks.com - Paid Partner Content
Novartis Filing for MabThera Biosimilar Accepted in the EU
May 24 / Zacks.com - Paid Partner Content
The 3 Best Dividend ETFs
May 15 / MotleyFool.com - Paid Partner Content
Exelixis' Kidney Cancer Drug Cabometyx Positive in Phase II
May 24 / Zacks.com - Paid Partner Content
Smart Investors Are Already Buying These Stocks for Retirement
May 15 / MotleyFool.com - Paid Partner Content
5 Smart IRA Moves You Can Make Now
May 24 / MotleyFool.com - Paid Partner Content
Vanguard Total Stock Market Index Fund -- Investing in Stocks the Easy Way
May 14 / MotleyFool.com - Paid Partner Content
4 Dow Members Bucking the Negative Trend
May 24 / Zacks.com - Paid Partner Content
Europe's corporate bond market hums ahead of ECB
May 13 / FT.com - Paid Partner Content
3 Stocks With Better Dividends Than Johnson & Johnson
May 24 / MotleyFool.com - Paid Partner Content
Google is worth more than Apple again
May 12 / CNNMoney.com
Ignore Intuitive Surgical, Inc.: Here Are 3 Better Stocks
May 23 / MotleyFool.com - Paid Partner Content
What now for the dollar: big questions for markets this week
May 08 / FT.com - Paid Partner Content
Novartis' Cardiovascular Drug Gets Positive Recommendation
May 23 / Zacks.com - Paid Partner Content
 Johnson & Johnson loses second cancer lawsuit
May 03 / CNNMoney.com
Triple-A quality fades as companies embrace debt
May 23 / FT.com - Paid Partner Content